Intracellular Ca 2+ Signalling and Phenotype of Vascular Smooth Muscle Cells

Basic and Clinical Pharmacology and Toxicology

Volumn 110, Issue 1, 2012, Pages 42-48

  Matchkov, Vladimir V ^a   Kudryavtseva, Olga ^a   Aalkjaer, Christian ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL; VOLTAGE GATED CALCIUM CHANNEL;

BLOOD VESSEL WALL; CALCIUM SIGNALING; CYTOSOL; GENE EXPRESSION; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PHENOTYPE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; GENE EXPRESSION REGULATION; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 83455185430     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00818.x     Document Type: Short Survey

References (60)

1. Yoshida T, Owens GK. Molecular determinants of vascular smooth muscle cell diversity. Circ Res 2005;96:280-91.
2. House SJ, Potier M, Bisaillon J, Singer HA, Trebak M. The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch 2008;456:769-85.
3. Heeneman S, Sluimer JC, Daemen MJ. Angiotensin-converting enzyme and vascular remodeling. Circ Res 2007;101:441-54.
4. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.
5. Wamhoff BR, Bowles DK, Owens GK. Excitation-transcription coupling in arterial smooth muscle. Circ Res 2006;98:868-78.
6. 2+ signaling and control of growth and proliferation. Biol Cell 2004;96:55-68.
7. 2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol 2008;295:C779-90.
8. 2+ pump in proliferating human arterial myocytes. Am J Physiol Cell Physiol 2009;297:C1103-12.
9. 2+ signal, transcription factor NFAT and proliferation in human vascular smooth muscle cells. J Mol Cell Cardiol 2011;50:621-33.
10. 2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat. Circ Res 2005;97:488-95.
11. Gollasch M, Haase H, Ried C, Lindschau C, Morano I, Luft FC et al. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J 1998; 12:593-601.
12. Lipskaia L, Pourci ML, Delomenie C, Combettes L, Goudouneche D, Paul JL et al. Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation. Circ Res 2003;92:1115-22.
13. 2+ -dependent vascular remodeling in the Syrian hamster. Am J Pathol 2007;171:162-71.
14. Aubart FC, Sassi Y, Coulombe A, Mougenot N, Vrignaud C, Leprince P et al. RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the rat. Mol Ther 2009;17:455-62.
15. Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, Singer HA et al. Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J 2009;23:2425-37.
16. Jaggar JH, Porter VA, Lederer WJ, Nelson MT. Calcium sparks in smooth muscle. Am J Physiol 2000;278:C235-56.
17. Cheng H, Lederer WJ. Calcium sparks. Physiol Rev 2008; 88:1491-545.
18. Aalkjaer C, Boedtkjer D, Matchkov V. Vasomotion - what is currently thought? Acta Physiol (Oxf) 2011;202:253-69.
19. Matchkov VV. Mechanisms of cellular synchronization in the vascular wall. Mechanisms of vasomotion. Dan Med Bull 2010;57:B4191.
20. Peng H, Matchkov V, Ivarsen A, Aalkjaer C, Nilsson H. Hypothesis for the initiation of vasomotion. Circ Res 2001;88:810-5.
21. Uhlen P, Burch PM, Zito CI, Estrada M, Ehrlich BE, Bennett AM. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling. Proc Natl Acad Sci U S A 2006;103:2160-5.
22. 2+ signal integrators. Proc Natl Acad Sci U S A 2008;105:2859-64.
23. Oancea E, Meyer T. Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell 1998;95:307-18.
24. 2+ oscillations. Trends Biochem Sci 2011;36:78-87.
25. 2+ oscillations. Science 1998;279:227-30.
26. Kumar MS, Owens GK. Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol 2003;23:737-47.
27. 2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ Res 2004;95:406-14.
28. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003;35:577-93.
29. 2+-dependent regulation in neuronal gene expression. Curr Opin Neurobiol 1997;7:419-29.
30. Barlow CA, Rose P, Pulver-Kaste RA, Lounsbury KM. Excitation-transcription coupling in smooth muscle. J Physiol 2006; 570(Pt 1):59-64.
31. 2+/calmodulin-dependent protein kinase IV activates cysteine-rich protein 1 through adjacent CRE and CArG elements. Am J Physiol Cell Physiol 2005;289:C785-93.
32. Sands WA, Palmer TM. Regulating gene transcription in response to cyclic AMP elevation. Cell Signal 2008;20:460-6.
33. Stevenson AS, Cartin L, Wellman TL, Dick MH, Nelson MT, Lounsbury KM. Membrane depolarization mediates phosphorylation and nuclear translocation of CREB in vascular smooth muscle cells. Exp Cell Res 2001;263:118-30.
34. 2+ channels. Circ Res 2000;86:760-7.
35. 2+-sensitive ion channels. Cell Calcium 2003;34:211-29.
36. 2+ entry activates the CREB transcription factor in vascular smooth muscle. Circ Res 2004;94:1351-8.
37. Wellman GC, Cartin L, Eckman DM, Stevenson AS, Saundry CM, Lederer WJ et al. Membrane depolarization, elevated Ca(2+) entry, and gene expression in cerebral arteries of hypertensive rats. Am J Physiol Heart Circ Physiol 2001;281:H2559-67.
38. Klemm DJ, Watson PA, Frid MG, Dempsey EC, Schaack J, Colton LA et al. cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration. J Biol Chem 2001;276:46132-41.
39. Watson PA, Nesterova A, Burant CF, Klemm DJ, Reusch JE. Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. J Biol Chem 2001;276:46142-50.
40. Klemm DJ, Majka SM, Crossno JT Jr, Psilas JC, Reusch JE, Garat CV. Reduction of reactive oxygen species prevents hypoxia-induced CREB depletion in pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol 2011;58:181-91.
41. Hill-Eubanks DC, Gomez MF, Stevenson AS, Nelson MT. NFAT regulation in smooth muscle. Trends Cardiovasc Med 2003;13:56-62.
42. 2+ response amplitude and duration. Nature 1997;386:855-8.
43. Pang X, Sun NL. Calcineurin-NFAT signaling is involved in phenylephrine-induced vascular smooth muscle cell proliferation. Acta Pharmacol Sin 2009;30:537-44.
44. Nilsson LM, Sun ZW, Nilsson J, Nordstrom I, Chen YW, Molkentin JD et al. Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol 2007;292:C1167-78.
45. Liu Z, Zhang C, Dronadula N, Li Q, Rao GN. Blockade of nuclear factor of activated T cells activation signaling suppresses balloon injury-induced neointima formation in a rat carotid artery model. J Biol Chem 2005;280:14700-8.
46. 2+ oscillation. EMBO J 2003;22:3825-32.
47. 2+ entry and NFAT activation in lymphocytes. Cell Calcium 2007;42:145-56.
48. 2+ signaling. J Biol Chem 2001;276:15018-24.
49. Gomez MF, Stevenson AS, Bonev AD, Hill-Eubanks DC, Nelson MT. Opposing actions of inositol 1, 4, 5-trisphosphate and ryanodine receptors on nuclear factor of activated T-cells regulation in smooth muscle. J Biol Chem 2002;277:37756-64.
50. 2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension. Proc Natl Acad Sci U S A 2008;105:15623-8.
51. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res 1996;79:14-9.
52. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004;428:185-9.
53. Topouzis S, Majesky MW. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. Dev Biol 1996;178:430-45.
54. Bochaton-Piallat ML, Clowes AW, Clowes MM, Fischer JW, Redard M, Gabbiani F et al. Cultured arterial smooth muscle cells maintain distinct phenotypes when implanted into carotid artery. Arterioscler Thromb Vasc Biol 2001;21:949-54.
55. Bochaton-Piallat ML, Gabbiani G. Modulation of smooth muscle cell proliferation and migration: role of smooth muscle cell heterogeneity. Handb Exp Pharmacol 2005;170:645-63.
56. Adams LD, Geary RL, McManus B, Schwartz SM. A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res 2000;87:623-31.
57. Madsen CS, Regan CP, Hungerford JE, White SL, Manabe I, Owens GK. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence. Circ Res 1998;82:908-17.
58. Manabe I, Owens GK. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest 2001;107:823-34.
59. Manabe I, Owens GK. The smooth muscle myosin heavy chain gene exhibits smooth muscle subtype-selective modular regulation in vivo. J Biol Chem 2001;276:39076-87.
60. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts - effects on survival over a 15-year period. N Engl J Med 1996;334:216-9.